Sight Sciences, Inc. (SGHT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$8.35-0.36%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · SGHT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 13.9% |
| Our one-year growth estimate | diamond | 15.7% |
Growth built into the price is above our model estimate.
The price assumes 1.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
SGHT — General Counsel transition
Dated 2026-08-10
Chief Legal Officer — Kashif Rashid: The company appointed an external candidate to fill the Chief Legal Officer role, which is a standard executive hiring event rather than a departure.
Why it matters: Higher operating expenses can hurt financial results. It shows how well the company controls costs.
Worry ifOperating costs are over $96M for 2026.
Less concerning ifOperating costs are under $93M for 2026.
Why it matters: The lawsuit outcome can change the company's market position. It also affects investor trust.
Watch forA favorable ruling in the patent case against Alcon.
Also watch forA bad ruling in the patent case against Alcon.
Why it matters: Lower operating costs show good cost control. This can help make more money.
Supportive ifAdjusted operating costs drop below $22 million in Q3 2026.
Worry ifAdjusted operating costs rise above $23 million in Q3 2026.
Why it matters: If sector revenue growth picks up, it may benefit Sight Sciences. This could improve overall market conditions.
Supportive ifSector revenue growth exceeds 10% year over year.
Worry ifSector revenue growth remains below 5% year over year.
Why it matters: The outcome of this appeal could impact future revenue from royalties. It is a key risk factor for the company.
Watch forA favorable ruling in the appeal that maintains the $55.4 million judgment.
Also watch forThe appeal results in a reversal of the judgment or reduced royalty rates.
Why it matters: An increase in revenue guidance shows the company is confident in growth. This could improve investor sentiment.
Supportive ifThe company raises its revenue guidance for 2026 above $89M.
Worry ifRevenue guidance remains at $83-$89M or is lowered.
Why it matters: Court case results can affect the company's image and finances. Good results may increase trust.
Watch forA good ruling in the current patent case.
Also watch forA ruling against the company in the patent infringement case.
Why it matters: Confirmation of guidance shows strong performance and market trust.
Supportive ifManagement confirms revenue for 2026 will be between $88 million and $92 million.
Worry ifManagement lowers revenue for 2026 to less than $88 million.
Why it matters: Continued strong growth in this segment is key for overall revenue momentum.
Supportive ifInterventional Dry Eye revenue exceeds $3 million in Q3 2026.
Worry ifInterventional Dry Eye revenue falls below $2 million in Q3 2026.
Why it matters: Lower operating costs help keep finances healthy. They also help with cash management.
Supportive ifOperating costs are below $22 million for Q3 2026.
Worry ifOperating costs are over $22 million in Q3 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$242 on $10,000 · ±2.4% | How much price usually moves either way. |
| Bad day | $648 loss on $10,000 · 6.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,188 loss on $10,000 · 61.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.